Search results
Results From The WOW.Com Content Network
The FDA issued a 2006 advisory against smoked medical cannabis stating: "marijuana has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision." [72]
The scientific debate regarding taxonomy has had little effect on the terminology in widespread use among cultivators and users of drug-type Cannabis. Cannabis aficionados recognize three distinct types based on such factors as morphology, native range, aroma, and subjective psychoactive characteristics. "Sativa" is the most widespread variety ...
Δ 9-tetrahydrocannabinol (THC) Cannabis sativa, scientific drawing from c. 1900 Although the main psychoactive constituent of Cannabis is tetrahydrocannabinol (THC), the plant is known to contain more than 500 compounds, among them at least 113 cannabinoids ; however, most of these "minor" cannabinoids are only produced in trace amounts. [ 10 ]
However, there are options for adults 21 and over in states where recreational marijuana use is legal, who can visit a verified dispensary to test the benefits of marijuana for their medical ...
The purpose of the act was to prohibit all non-medical use of cannabis in the U.S.; however, it also had the effect of severely curtailing medical use of the drug, due to new fees and regulatory requirements put in place that imposed a significant burden on doctors prescribing cannabis. [13]
Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with some scientific support for its use as a medical treatment, researchers from the US ...
The National Institute on Drug Abuse determined that marijuana use is "likely to precede use of other licit and illicit substances" and that "adults who reported marijuana use during the first wave of the survey were more likely than adults who did not use marijuana to develop an alcohol use disorder within 3 years; people who used marijuana ...
Although cannabis is legalized for medical uses in more than half of the states of the United States, no products have been approved for federal commerce by the Food and Drug Administration, a status that limits cultivation, manufacture, distribution, clinical research, and therapeutic applications.